• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Infectious Disease

ICU chlorhexidine baths do not reduce rates of hospital-acquired infections

byJeffrey CohenandPriyanka Vedak
January 21, 2015
in Infectious Disease, Public Health
Reading Time: 3 mins read
ICU chlorhexidine baths do not reduce rates of hospital-acquired infections
Share on FacebookShare on Twitter

1. In this study, daily bathing with chlorhexidine did not decrease the rates of hospital-acquired infections in ICU patients.

2. The hospital-acquired infections that were assessed in this study included central line associated blood stream infections (CLABSI), catheter-associated urinary tract infections (CAUTI), ventilator associated pneumonia (VAP), and C. difficile infections.

Evidence Rating Level: 1 (Excellent)

Study Rundown: Chlorhexidine is a topical broad spectrum antimicrobial that has been used to try to decrease the incidence of hospital-acquired infections in patients in the intensive care unit (ICU). This study utilized cluster randomization to compare rates of central line associated infections, catheter-associated urinary tract infections, ventilator associated pneumonia, and C. difficile infections between individuals in the ICU bathed with and without chlorhexidine. The study included 10,783 individuals treated in five ICUs. There was no difference in the rate of infections between the two study groups after controlling for demographic information and known prognostic factors such as comorbidities. Strengths of this study include the cluster randomization, use of multiple significant outcomes, and inclusion of ICUs from five tertiary care centers. The major weakness of this study is the inability to blind the care providers in the ICUs due to the difference in scent between the chlorhexidine and control cleaning materials. Another weakness is the lack of assessment of rate of adherence. This study suggests that bathing ICU patients with chlorhexidine does not result in a decrease in hospital-acquired infections, but a larger and longer study may be helpful in determining whether specific patients would benefit from this practice.

Click to read the study, published today in JAMA

Click to read an accompanying editorial, published today in JAMA

RELATED REPORTS

Low bicarbonate replacement fluid may lead to a more stable acid-base profile compared with high bicarbonate replacement fluid during continuous veno-venous hemofiltration

2 Minute Medicine Rewind November 24, 2025

The Yang-Tobin Index: A Key Predictor for Successful Extubation in Critical Care

Relevant Reading: Effect of Daily Chlorhexidine Bathing on Hospital-Acquired Infection

In-Depth [cluster randomized study]: This study used cluster randomization to randomize 10,783 individuals admitted to ICUs in five tertiary care centers in the US to daily bathing with chlorhexidine or non-antimicrobial solution. The rates of central line associated infections, catheter-associated urinary tract infections (UTIs), ventilator associated pneumonia, and C. difficile infections were compared between the two groups over a 1-year period. During the time of chlorhexidine bath use 55 infections were recorded, while 60 infections were recorded during the control period. This resulted in no statistically significant difference in the rates of infection between the two groups, even after controlling for demographic factors, comorbidities, time, admission white blood cell count, and type of ICU (RR 0.94; 95%CI 0.65-1.37). There was also no difference when the ICU types (medical, surgical, trauma, cardiovascular, neurological) were analyzed individually. While in-hospital mortality initially appeared to be reduced with use of chlorhexidine baths (8.14% vs. 9.31%; 95CI -2.3 to -0.03), this finding was no longer significant when baseline variable were taken into account.

More from this author: Ambulances equipped for thrombolysis allow for more rapid stroke treatment, Stem cell transplant may be effective in sickle cell disease, Adding sargramostim to ipilimumab may improve survival in advanced melanoma, No change in health or education outcomes following implementation of duty-hour restrictions, HPV vaccine not associated with Multiple Sclerosis

Image: CC/Calleamanecer

©2015 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. No article should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2 Minute Medicine, Inc.

Tags: Chlorhexidineintensive care
Previous Post

Incidental findings common with breast imaging, often benign

Next Post

CT may be superior to MRI for pituitary tumor detection

RelatedReports

Emergency

Low bicarbonate replacement fluid may lead to a more stable acid-base profile compared with high bicarbonate replacement fluid during continuous veno-venous hemofiltration

January 13, 2026
Elective colectomy associated with improved survival in ulcerative colitis
Weekly Rewinds

2 Minute Medicine Rewind November 24, 2025

November 24, 2025
Palliative chemotherapy associated with more ICU treatment at end-of-life
Career Development

The Yang-Tobin Index: A Key Predictor for Successful Extubation in Critical Care

October 7, 2025
Dasatinib and blinatumomab treatment for acute lymphoblastic leukemia
Cardiology

Various biomarkers remain intact in delayed sample processing

November 9, 2024
Next Post
CT may be superior to MRI for pituitary tumor detection

CT may be superior to MRI for pituitary tumor detection

H. Pylori infection influenced by genes

Helicobacter pylori infection may protect against Multiple Sclerosis in women

Deaths of extremely premature infants decrease, necrotizing enterocolitis deaths on the rise

Deaths of extremely premature infants decrease, necrotizing enterocolitis deaths on the rise

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Earlier Genetic Testing Predicts Bilateral Mastectomy in Young BRCA Carriers
  • Uterine-Sparing Mesh Repair Outperforms Hysterectomy for Prolapse
  • Daraxonrasib showed antitumor activity in previously treated RAS-mutant non–small-cell lung cancer
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.

2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in